Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 6/20 | 0.42 |
| ▸ | FAP | Q12884 | 4/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2411177 | 1.00 | EPHX2 (0.62) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| Hydrochloric Acid SCHEMBL75462 | 0.98 | EPHX2 (0.61) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| SCHEMBL1977433 | 0.98 | EPHX2 (0.59) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| Hydrochloric Acid SCHEMBL6871695 | 0.96 | EPHX2 (0.58) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| Hydrochloric Acid SCHEMBL7131992 | 0.94 | EPHX2 (0.57) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| SCHEMBL7440501 | 0.94 | EPHX2 (0.55) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| SCHEMBL4450020 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL7134822 | 0.88 | EPHX2 (0.51) | EPHX2NPSR1KDM4EPOLBDPP7 | |
| Hydrochloric Acid SCHEMBL76321 | 0.87 | EPHX2 (0.47) | EPHX2KDM4EDPP7MEN1KMT2A | |
| SCHEMBL1320792 | 0.82 | KDM4E (0.56) | EPHX2NPSR1KDM4EPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | BRIGHAM YOUNG UNIVERSITY (US) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170128489-A1 | ORGANO-TRANSITION METAL COMPLEXES FOR THE TREATMENT OF VIRAL INFECTIONS | HVCN1, TRPM8, TRPM2 | EPHX2 4833/4885NPSR1 1494/4885KDM4E 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.